Non Active Secondary Progressive Multiple Sclerosis Spms clinical trials

Explore recruiting non active secondary progressive multiple sclerosis spms clinical trials.

Also recruiting in Europe

Non Active Secondary Progressive Multiple Sclerosis Spms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Germany, Bulgaria, Netherlands, Sweden, Portugal, Croatia +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Non Active Secondary Progressive Multiple Sclerosis Spms trials by city

Non Active Secondary Progressive Multiple Sclerosis Spms in Toronto Non Active Secondary Progressive Multiple Sclerosis Spms in Vancouver Non Active Secondary Progressive Multiple Sclerosis Spms in Montreal Non Active Secondary Progressive Multiple Sclerosis Spms in Calgary Non Active Secondary Progressive Multiple Sclerosis Spms in Edmonton Non Active Secondary Progressive Multiple Sclerosis Spms in Ottawa Non Active Secondary Progressive Multiple Sclerosis Spms in Winnipeg Non Active Secondary Progressive Multiple Sclerosis Spms in Quebec City Non Active Secondary Progressive Multiple Sclerosis Spms in Hamilton Non Active Secondary Progressive Multiple Sclerosis Spms in Kitchener Non Active Secondary Progressive Multiple Sclerosis Spms in London Non Active Secondary Progressive Multiple Sclerosis Spms in Halifax Non Active Secondary Progressive Multiple Sclerosis Spms in New York Non Active Secondary Progressive Multiple Sclerosis Spms in Los Angeles Non Active Secondary Progressive Multiple Sclerosis Spms in Chicago Non Active Secondary Progressive Multiple Sclerosis Spms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease